Clinical Trial Update: Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating neoadjuvant trastuzumab and letrozole in postmenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN